[1] |
Acera A, Rocha G, Vecino E, et al. Inflammatory markers in the tears of patients with ocular surface disease[J]. Ophthalmic Res, 2008, 40(6): 315-321.
|
[2] |
Chotikavanich S, de-Paiva-CS, Li de Q, et al. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome[J]. Invest Ophthalmol Vis Sci, 2009, 50(7): 3203-3209.
|
[3] |
Lanza NL, Valenzuela F, Perez VL, et al. The matrix metalloproteinase 9 point-of-care test in dry eye[J]. Ocul Surf, 2016, 14(2): 189-195.
|
[4] |
亚洲干眼协会中国分会,海峡两岸医药卫生交流协会眼科学专业委员会眼表与泪液病学组,中国医师协会眼科医师分会眼表与干眼学组. 中国干眼专家共识:检查和诊断(2020年)[J].中华眼科杂志,2020,56(10):741-747.
|
[5] |
Schiffman RM, Christianson MD, Jacobsen G, et al. Reliability and validity of the ocular surface disease index[J]. Arch Ophthalmol, 2000, 118(5): 615-621.
|
[6] |
Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests[J]. Cornea, 2003, 22(7): 640-650.
|
[7] |
Behrens A, Doyle JJ, Stern L, et al. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations[J]. Cornea, 2006, 25(8): 900-907.
|
[8] |
韦振宇,刘含若,梁庆丰. 我国干眼流行病学的研究进展[J].中华眼科医学杂志(电子版),2020,10(1):46-50.
|
[9] |
Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS Ⅱ definition and classification report[J]. Ocul Surf, 2017,15(3): 276-283.
|
[10] |
Baudouin C, Aragona P, Messmer EM, et al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting[J]. Ocul Surf, 2013,11(4): 246-258.
|
[11] |
许宇东,王修珍,朱江莉,等. 基质金属蛋白酶在兔干眼症动物模型中的表达[J]. 眼科新进展,2011,31(2):131-134,146.
|
[12] |
Aragona P, Aguennouz M, Rania L, et al. Matrix metalloproteinase 9 and transglutaminase 2 expression at the ocular surface in patients with different forms of dry eye disease[J]. Ophthalmology, 2015,122(1): 62-71.
|
[13] |
Pflugfelder SC. Anti-inflammatory therapy of dry eye[J]. Ocul Surf, 2003, 1(1): 31-36.
|
[14] |
Zoukhri D. Effect of inflammation on lacrimal gland function[J]. Exp Eye Res, 2006, 82(5): 885-898.
|
[15] |
Tseng HC, Lee IT, Lin CC, et al. IL-1β promotes corneal epithelial cell migration by increasing MMP-9 expression through NF-κB- and AP-1-dependent pathways[J]. PLoS One, 2013, 8(3): e57955.
|
[16] |
Hessen M, Akpek EK. Dry eye: an inflammatory ocular disease[J]. J Ophthalmic Vis Res, 2014, 9(2): 240-250.
|
[17] |
Pflugfelder SC, Farley W, Luo L, et al. Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye[J]. Am J Pathol, 2005,166(1): 61-71.
|
[18] |
Lin CC, Kuo CT, Cheng CY, et al. IL-1 beta promotes A549 cell migration via MAPKs/AP-1 and NF-kappaB-dependent matrix metalloproteinase-9 expression[J]. Cell Signal, 2009, 21(11): 1652-1662.
|
[19] |
林辉. 应激及炎症因素在干眼发病中的作用[D]. 广州:中山大学,2009.
|
[20] |
Sambursky R, Davitt WF, Latkany R, et al. Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye[J]. JAMA Ophthalmol, 2013, 131(1): 24-28.
|
[21] |
Liu X, Wang G, He J, et al. Novel application of immunochromatographic assay for measurement of total tear immunoglobulin E[J]. Cornea, 2024, 43(1): 13-17.
|
[22] |
北京医学会检验分会. 感染性眼病的病原微生物实验室诊断专家共识[J].中华检验医学杂志,2022,45(1):14-23.
|
[23] |
万惜晨,张洪,沈燕,等. 国产泪液MMP9试剂盒快速检测的初步对比研究[J]. 中华眼科杂志,2023,59(4):272-278.
|